Social Activist Demands Lab Testing Of Ayurvedic Medicine Used For Joint Pains

Jammu: (UNI) A Jammu based social activist Sukesh C Khajuria has sought laboratory testing of Ayurvedic medicine, being used for treating the joint pains.

The social activist had expressed his apprehensions related to the Ayurvedic composition known as ‘Batnashak Batika”, which he claimed is increasingly being utilized for the treatment of joint pains, particularly in patients who have suffered from ‘Chikungunya’ in Jammu and Kashmir. He wrote to the drug authorities in J&K that ‘Batnashak Batika’ reportedly demonstrates swift efficacy in alleviating post-Chikungunya joint pains, contrary to the conventional understanding that Ayurvedic herbal medicines typically facilitate gradual healing and recovery.

Given the remarkable and expeditious healing attributed to this Ayurvedic medicine, I harbour reservations regarding its composition,” he added.

He requested the Drug controller Jammu and Kashmir to conduct a thorough chemical examination of the composition to determine whether any steroids or potentially harmful substances have been incorporated to expedite relief, posing potential health risks to consumers. Khajuria and urged the authorities for a comprehensive chemical examination of the Ayurvedic medicine at the drug laboratory and disseminate the findings to the general public for the collective benefit of society.

He said he had alerted the drug authorities of Jammu and Kashmir, Union Health Minister and other central and union territory officials about the dangers of sale of such drugs.

Related Posts

Telangana official urges pharma sector to treat safety as a competitive edge, not a checkbox

Sarvesh Singh, Director and CEO of Telangana Lifesciences and Pharma, called on industry leaders at a CII Telangana conference to embed safety by design into manufacturing culture, deploying AI, IoT,…

CDSCO Approves Indian Pharma Companies for EU API Exports, Opening New Growth Opportunities

Amidst tariff tensions with the US, Europe has created a major opportunity for the Indian pharmaceutical industry. The CDSCO has granted approval to three Indian companies to export APIs to…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Telangana official urges pharma sector to treat safety as a competitive edge, not a checkbox

Telangana official urges pharma sector to treat safety as a competitive edge, not a checkbox

CDSCO Approves Indian Pharma Companies for EU API Exports, Opening New Growth Opportunities

CDSCO Approves Indian Pharma Companies for EU API Exports, Opening New Growth Opportunities

Four booked for cheating pharma firm manager of ₹26 lakh with promise of PDO job

Four booked for cheating pharma firm manager of ₹26 lakh with promise of PDO job

Puducherry drugs inspector suspended after counterfeit medicine crackdown

Puducherry drugs inspector suspended after counterfeit medicine crackdown

Researchers discover a compound that can boost ageing muscle repair

Researchers discover a compound that can boost ageing muscle repair

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks

Madras HC Refuses To Quash FIR In Counterfeit Drug Case, Orders CBI To Complete Probe In 12 Weeks